Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofMesna and Ifosfamide Injection from Surat, Gujarat, India. Mesna AndIfosfamide Injection used in those taking cyclophosphamide or ifosfamide to decreasethe risk of bleeding from the bladder.
Tags: Mesna and Ifosfamide Injection manufacturer, Mesna and IfosfamideInjection exporter, Mesna and Ifosfamide Injection supplier,and Mesna and Ifosfamide Injection, whogmp approved Mesna and Ifosfamide Injectionmanufacturer and supplier, Mesna and Ifosfamide Injection distributor,Mesna and Ifosfamide Injection shipper, Mesna and Ifosfamide Injection 2 ml Mesna AndIfosfamide Injection 2mlsupplier, Mesna and Ifosfamide Injection2 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested in registrationof own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceMesna and Ifosfamide Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Comprehensive Protection During ChemotherapyMesna and Ifosfamide Injection provides significant clinical benefit by reducing Ifosfamide-induced toxicity, notably hemorrhagic cystitis, in patients undergoing chemotherapy. This combination enables patients to tolerate Ifosfamide treatment more safely. The solution is supplied in a glass vial for intravenous administration, ensuring delivery straight into the bloodstream for effective action.
Safety, Compatibility, and QualityThe injection features a clear, odorless formula, neutral to slightly alkaline in pH (7.0-8.0), and is compatible with standard saline infusions. With careful manufacturing standards, every vial is sealed and approved as per local regulations. Healthcare providers should monitor patients for allergic reactions and ensure proper hydration, while avoiding use in those with hypersensitivity to Mesna or Ifosfamide.
FAQ's of Mesna and Ifosfamide Injection:
Q: How should Mesna and Ifosfamide Injection be administered?
A: This product is intended for intravenous use only and should be administered by a qualified healthcare professional. It is typically infused using standard saline as a compatible solvent.
Q: What is the main clinical benefit of using Mesna and Ifosfamide Injection?
A: The primary benefit is the prevention of Ifosfamide-induced hemorrhagic cystitis, allowing cancer patients to safely receive Ifosfamide as part of their chemotherapy regimen.
Q: When is Mesna and Ifosfamide Injection prescribed?
A: This injection is prescribed during cancer chemotherapy, specifically in cases where Ifosfamide is used, to minimize bladder toxicity and related complications.
Q: Where should the vials be stored to maintain their efficacy?
A: Vials should be stored in a cool and dry place, sheltered from direct light and moisture, to ensure the solution's stability throughout its two-year shelf life.
Q: What precautions must be taken during the administration of this injection?
A: Healthcare providers should monitor for potential allergic reactions and confirm adequate hydration status of the patient throughout therapy. Do not use in individuals with known hypersensitivity to Mesna or Ifosfamide.
Q: Is the injection compatible with other infusion fluids?
A: Yes, it is compatible with standard saline infusion, but always follow medical guidelines for dilution and administration.